83 Results

People

  1. Kris
    Kris
  2. Chou
    Chou
  3. Fair
    Fair
  4. Motzer
    Motzer
  5. O'Reilly
    O'Reilly
  6. Rabbani
    Rabbani
  7. Bastar
    Bastar
  8. Fong
    Fong
  9. Hellmann
    Hellmann
  10. Morris
    Morris

Groups

  1. Department of Medicine (53)
  2. Solid Tumor Oncology Division (49)
  3. Genitourinary Oncology Service (14)
  4. Thoracic Oncology (13)
  5. Sloan Kettering Institute Postdocs (10)
  6. Surgery (10)
  7. Breast Medicine Service (9)
  8. Center for Pancreatic Cancer Research (9)
  9. GSK Faculty (9)
  10. Epidemiology and Biostatistics (8)
  1. "combination"
Formats
  1. Journal Article (69)
  2. Review (7)
  3. Conference Paper (3)
  4. Book Section (2)
  5. Editorial (1)
  6. Meeting Abstract (1)
Groups
  1. Department of Medicine (53)
  2. Solid Tumor Oncology Division (49)
  3. Genitourinary Oncology Service (14)
  4. Thoracic Oncology (13)
  5. Sloan Kettering Institute Postdocs (10)
  6. Surgery (10)

More Groups

People
  1. Ting-Chao Chou (6)
  2. Mark Kris (5)
  3. Eileen O'Reilly (4)
  4. Farhang Rabbani (4)
  5. Robert Motzer (4)
  6. William Fair (4)

More People

Years
  1. 2025 (2)
  2. 2024 (1)
  3. 2023 (6)
  4. 2022 (3)
  5. 2021 (6)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (17)
  2. Journal for ImmunoTherapy of Cancer (5)
  3. Annals of Oncology (3)
  4. Clinical Cancer Research (3)
  5. Molecular Urology (3)
  6. Seminars in Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (19)
  2. Elsevier Inc. (8)
  3. Oxford University Press (6)
  4. American Association for Cancer Research (5)
  5. Biomed Central Ltd (5)
  6. Elsevier Science, Inc. (4)

More Publishers

Results (83)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer
    Journal Article

    Friedman, C. F.; Snyder Charen, A.; Zhou, Q.; Carducci, M. A.; Buckley De Meritens, A.; Corr, B. R.; Fu, S.; Hollmann, T. J.; Iasonos, A.; Konner, J. A.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Immunological combination treatment holds the key to improving survival in pancreatic cancer
    Review

    Sodergren, M. H.; Mangal, N.; Wasan, H.; Sadanandam, A.; Balachandran, V. P.; Jiao, L. R.; Habib, N.
    Journal of Cancer Research and Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase 1 study of epacadostat in combination with atezolizumab for patients with previously treated advanced nonsmall cell lung cancer
    Journal Article

    Hellmann, M. D.; Gettinger, S.; Chow, L. Q. M.; Gordon, M.; Awad, M. M.; Cha, E.; Gong, X.; Zhou, G.; Walker, C.; Leopold, L.; more...
    International Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Probody therapeutics: An emerging class of therapies designed to enhance on-target effects with reduced off-tumor toxicity for use in immuno-oncology
    Review

    Autio, K. A.; Boni, V.; Humphrey, R. W.; Naing, A.
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • TATTON: A multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer
    Journal Article

    Oxnard, G. R.; Yang, J. C. H.; Yu, H.; Kim, S. W.; Saka, H.; Horn, L.; Goto, K.; Ohe, Y.; Mann, H.; Thress, K. S.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Outcomes for relapsed and refractory peripheral T-cell lymphoma patients after front-line therapy from the COMPLETE registry
    Journal Article

    Lansigan, F.; Horwitz, S. M.; Pinter-Brown, L. C.; Rosen, S. T.; Pro, B.; Hsi, E. D.; Federico, M.; Gisselbrecht, C.; Schwartz, M.; Bellm, L. A.; more...
    Acta Haematologica (2020)

    Fulltext@MSK | Save
  • How I treat metastatic pancreatic cancer with emerging therapies
    Book Section

    Krantz, B. A.; O'Reilly, E. M.
    In Bekaii-Saab, T.; El-Rayes, B. F.; Pawlik, T. M. (Eds.) Handbook of Gastrointestinal Cancers: Evidence-Based Treatment and Multidisciplinary Patient Care (2020)

    Fulltext@MSK | Save
  • Lurbinectedin (L) combined with paclitaxel (P) or irinotecan (I) in relapsed SCLC. Results from two phase Lb trials
    Meeting Abstract

    Ponce, S.; Calvo, E.; De Miguel, M. J.; Sessa, C.; Flor, M. J.; Drilon, A.; Falcon, A.; Sanchez Simon, I.; Nuñez, R.; Luepke, X. E.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Sequencing and combination of systemic therapy in metastatic renal cell carcinoma
    Review

    de Velasco, G.; Bex, A.; Albiges, L.; Powles, T.; Rini, B. I.; Motzer, R. J.; Heng, D. Y. C.; Escudier, B.
    European Urology Oncology (2019)

    Fulltext@MSK | Save
  • Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors
    Journal Article

    Hellmann, M. D.; Kim, T. W.; Lee, C. B.; Goh, B. C.; Miller, W. H. Jr; Oh, D. Y.; Jamal, R.; Chee, C. E.; Chow, L. Q. M.; Gainor, J. F.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save